Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

House panel debates greater FDA role in regulating health apps

The safety, effectiveness and data security of mobile healthcare applications were examined by a U.S. House subcommittee in a July 13 hearing, with lawmakers alternating between excitement over their potential and concern that consumers’ data isn’t being protected.

Thumbnail

Senate passes anti-opioid abuse bill despite Dems’ funding concerns

A 92-2 vote in the U.S. Senate will send a legislative package aimed at fighting opioid addiction and abuse to President Barack Obama, who has promised to sign it even though it doesn’t contain the $1.1 billion in extra funding he requested for treatment and prevention programs.

Burwell: ACA too ingrained to repeal

There are only about six months left in President Obama’s tenure at the White House, which means his administration is about to lose their jobs too. But some of them have a lot of work to do before they go. 

Thumbnail

CMS’s Slavitt says MACRA could be delayed

Testifying before the Senate Finance Committee, CMS Acting Administrator said it’s possible the agency will push back the Jan. 1, 2017, date for physicians to begin reporting under new standards set up by the Medicare Access and CHIP Reauthorization Act (MACRA).

Illinois co-op will shut down, leaving 49,000 looking for new coverage

Only seven of the original 23 health insurance co-ops set up by the Affordable Care Act will still be in operation, as Illinois’ Land of Lincoln Health (LLH) becomes the latest to close over risk adjustment payments.

21st Century Cures Act won’t get Senate vote before long recess

It’s been more than a year since the House passed the 21st Century Cures Act, which aims to speed up regulatory approval for medical devices and drugs, but the Senate’s chief advocate for the legislation said it’ll be at least another seven weeks before its put up for a vote.

AMA gives mixed reaction to CMS physician fee changes for 2017

The American Medical Association’s initial reaction to the proposed physician fee schedule for 2017 called the rule “a mix of meritorious and flawed proposals.”

Thumbnail

HHS issues new guidance on ransomware attacks

HHS’ Office of Civil Rights (OCR) has released its much-anticipated guidance on how healthcare organizations can better understand and respond to ransomware attacks, including defining such incidents as breaches that require affected individuals to be notified under HIPAA in most circumstances.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.